Quoin Pharmaceuticals Ltd DRC (QNRX NASDAQ) stock market data APIs
$6.7883
0.02(0.3%)
as of September 11, 2026
Try our APIs with
free plan!
Quoin Pharmaceuticals Ltd DRC Financial Data Overview
Price chart is built with
Anychart
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Prev. Close
6.7883
Open
6.8037
High
6.8139
Low
6.7208
52 wk Range
3.25-23.5
Market Cap
13 637 K
Shares Outstanding
2 008 K
EPS
-1.9
Beta
1.726
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Quoin Pharmaceuticals Ltd DRC data using free add-ons & libraries
Get Quoin Pharmaceuticals Ltd DRC Fundamental Data
Quoin Pharmaceuticals Ltd DRC Fundamental data includes:
- Net Revenue:
- EBITDA: -19 045 144
- Earnings Per Share: -5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Quoin Pharmaceuticals Ltd DRC Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -1.83
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quoin Pharmaceuticals Ltd DRC News
New
Sector Update: Healthcare Stocks Decline Friday Afternoon
Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index and the State Street H PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Stocks open on mixed footing ahead of Warsh's Jackson Hole speech: AlphaCheck
Good morning. Stocks are off to a mixed start as all eyes turn toward Jackson Hole, where Kevin Warsh is set to give his first keynote speech as chairman of the Federal Reserve. In the bond market, yi...
Quoin Q2 Loss Widens; Gets FDA's Conditional Nod For QYLEKI Brand Name For QRX003
(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, reported second-quarter 2026 results and provided a corporate...
Quoin Pharma To Launch Phase 2 Study Of QRX003 In Peeling Skin Syndrome After FDA Clearance
(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX) on Thursday said the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application for QRX003 for the treatment of Peeling ...
Get Quoin Pharmaceuticals Ltd DRC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
